| 摘要 |
Provided are agonists of melanocortin receptor 4, comprising peptide sequence Cys-D-Ala-His-D-Phe-Arg-Trp-Cys and specified variants thereof, and hydantoin conjugates of the peptides. The compounds are useful for treating insulin resistance in e.g. diabetes. |
